Pharmaceutical Supply Chain Initiative Proudly Welcomes WuXi AppTec as Strategic Partner

WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative to Strengthen Responsible Practices and Supply Chain Resilience

Pharmaceutical Supply WuXi AppTec, a global leader providing comprehensive research, development, and manufacturing services to the pharmaceutical and life sciences industries, has announced its new partnership with the Pharmaceutical Supply Chain Initiative (PSCI). The company has officially joined the initiative as a Supplier Partner, reinforcing its ongoing commitment to promoting responsible business practices and strengthening the resilience of the pharmaceutical supply chain.

The PSCI is a renowned global non-profit membership organization dedicated to promoting ethical, responsible, and sustainable supply chains within the pharmaceutical and healthcare sectors. The initiative aims to advance its three pillars of impact—Audit, Capability, and Projects—fostering improvements in safety, environmental sustainability, and social responsibility across the global pharmaceutical and healthcare value chain.

Pharmaceutical Supply WuXi AppTec’s decision to become a Supplier Partner with the PSCI reflects its alignment with these key values and its dedication to meeting the highest standards of corporate social responsibility. By becoming part of this collaborative network, WuXi AppTec aims to further its mission of delivering innovative therapies while simultaneously enhancing its contributions to a more sustainable and ethical global supply chain.

“We are pleased to join the PSCI as a Supplier Partner and reaffirm our commitment to fostering responsible business practices across the global supply chain,” said Edward Hu, Vice Chairman of WuXi AppTec and Chairman of the company’s Environmental, Social, and Governance (ESG) Committee. “By adhering to PSCI standards and continuously enhancing our value chain management practices, we remain steadfast in our dedication to supporting our customers in delivering groundbreaking new therapies to patients. Together, we can work toward a healthier, more sustainable future.”

Pharmaceutical Supply WuXi AppTec’s Role in the Global Life Sciences Industry

As a key player in the global pharmaceutical and life sciences industry, Pharmaceutical Supply WuXi AppTec is a trusted partner known for enabling innovation across the entire drug development lifecycle. The company’s vast range of services spans drug discovery, development, and manufacturing, offering end-to-end solutions to its clients. By joining the PSCI, WuXi AppTec further strengthens its role as a responsible enabler of life-saving innovations in the healthcare space.

Incorporating environmental, social, and governance (ESG) considerations is central to WuXi AppTec’s operations. The company recognizes that responsible business practices are critical not only for its own success but for the success of its partners and the well-being of the global community. WuXi AppTec’s commitment to ESG is evident in its numerous achievements in sustainability and corporate responsibility.

WuXi AppTec’s Commitment to Sustainability and ESG

Pharmaceutical Supply WuXi AppTec has consistently integrated ESG priorities into all facets of its business. The company’s dedication to sustainability was widely recognized in 2024 when it earned the top spot in the Global Life Sciences Tools & Services Industry in S&P Global’s Corporate Sustainability Assessment. WuXi AppTec was also awarded a gold medal in the EcoVadis business sustainability rating, underscoring its leadership in responsible corporate practices.

In addition to these accolades, WuXi AppTec was included in the prestigious 2024 Dow Jones Sustainability Indices (DJSI), further solidifying its commitment to sustainable business operations. The company has maintained its AA rating in the MSCI ESG assessment for four consecutive years, demonstrating its consistent focus on ESG excellence.

Pharmaceutical Supply WuXi AppTec’s commitment to sustainability and responsible business practices is also reflected in its ongoing inclusion in notable global sustainability indices. In both 2023 and 2024, the company was featured in the S&P Global Sustainability Yearbook, which recognizes companies that demonstrate leadership in environmental, social, and governance performance. WuXi AppTec also earned a spot in the FTSE4Good Index Series, which highlights companies that meet globally recognized ESG standards.

Sustainalytics, a leading provider of ESG research and ratings, named WuXi AppTec an “Industry and Regional Top-Rated” company, reflecting its leadership in sustainable practices. These recognitions serve as a testament to WuXi AppTec’s unwavering commitment to integrating ESG principles into its global operations and value chain.

Supporting Global Sustainability through the United Nations Global Compact and the Science Based Targets Initiative

Pharmaceutical Supply WuXi AppTec’s involvement in the global sustainability movement extends beyond its own operations. In 2024, the company joined the United Nations Global Compact (UNGC), a voluntary initiative for businesses committed to aligning their strategies with ten universal sustainability principles covering areas such as human rights, labor standards, environmental impact, and anti-corruption measures. By joining the UNGC, WuXi AppTec affirms its dedication to advancing global sustainability goals and fostering a better, more equitable world.

In 2023, WuXi AppTec also became a signatory of the Science Based Targets initiative (SBTi), a global organization that encourages businesses to set carbon reduction goals that are in line with climate science. Through its commitment to the SBTi, WuXi AppTec has set ambitious targets for reducing its carbon emissions, contributing to the global effort to mitigate climate change.

WuXi AppTec’s participation in both the UNGC and SBTi aligns with the company’s broader ESG goals, ensuring that its growth is sustainable and responsible, benefiting not only its stakeholders but also the environment and society at large.

WuXi AppTec’s Long-Term Vision for Responsible Business Practices

WuXi AppTec’s decision to join the PSCI marks an important step in the company’s long-term strategy for responsible business practices and supply chain resilience. By working closely with other members of the PSCI, WuXi AppTec is strengthening its ability to drive positive change across its value chain. The company aims to influence improvements in safety standards, environmental practices, and social outcomes throughout the pharmaceutical supply chain, ultimately benefiting patients, healthcare providers, and the global community.

As a Supplier Partner, WuXi AppTec will contribute to and benefit from the PSCI’s initiatives, which include driving improvements in supply chain transparency, strengthening capabilities, and promoting joint projects focused on sustainability and social responsibility. Through these efforts, WuXi AppTec hopes to not only enhance its own operations but also play a pivotal role in advancing the pharmaceutical and healthcare sectors toward more responsible and sustainable practices.

A Stronger, More Sustainable Future for the Pharmaceutical Industry

WuXi AppTec’s partnership with the Pharmaceutical Supply Chain Initiative is a reflection of its continued dedication to advancing responsible business practices and building resilient, sustainable supply chains. By joining this influential global network, WuXi AppTec further solidifies its position as a leader in both the pharmaceutical services industry and the broader ESG movement.

Through its proactive involvement in initiatives like the PSCI, the UNGC, and the SBTi, WuXi AppTec is not only working to improve its own business practices but is also driving positive change across the entire pharmaceutical and life sciences value chain. As the company continues to innovate and support the development of new therapies for patients worldwide, its commitment to sustainability, ethics, and corporate responsibility will remain at the forefront of its operations.

WuXi AppTec’s participation in the PSCI marks the beginning of an exciting chapter in its journey toward a more sustainable, responsible, and resilient future for the pharmaceutical industry. By adhering to the highest standards of ESG excellence, WuXi AppTec is poised to make a lasting impact on the healthcare sector and the communities it serves.

Source Link

Newsletter Updates

Enter your email address below and subscribe to our newsletter